Pozo-Rosich, P., Poveda, J. L., Crespo, C., Martinez, M., Rodríguez, J. M., & Irimia, P. (2024). Is erenumab an efficient alternative for the prevention of episodic and chronic migraine in Spain? Results of a cost-effectiveness analysis.
Citación estilo ChicagoPozo-Rosich, Patricia|||0000-0003-0796-4702, José Luis Poveda, Carlos|||0000-0001-6066-0818 Crespo, Maria Martinez, José Manuel Rodríguez, y Pablo|||0000-0002-7238-0036 Irimia. Is Erenumab an Efficient Alternative for the Prevention of Episodic and Chronic Migraine in Spain? Results of a Cost-effectiveness Analysis. 2024.
Cita MLAPozo-Rosich, Patricia|||0000-0003-0796-4702, et al. Is Erenumab an Efficient Alternative for the Prevention of Episodic and Chronic Migraine in Spain? Results of a Cost-effectiveness Analysis. 2024.